Truvestments Capital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.22M | Buy |
25,027
+811
| +3% | +$94.9K | 0.48% | 52 |
|
|
2026
Q1 | $2.91M | Buy |
24,216
+12,759
| +111% | +$1.47M | 0.53% | 45 |
|
|
2025
Q4 | $1.21M | Sell |
11,457
-746
| -6% | -$70K | 0.22% | 108 |
|
|
2025
Q3 | $1.02M | Buy |
12,203
+8,592
| +238% | +$708K | 0.19% | 119 |
|
|
2025
Q2 | $286K | Buy |
3,611
+105
| +3% | +$8.35K | 0.06% | 219 |
|
|
2025
Q1 | $315K | Sell |
3,506
-545
| -13% | -$50.9K | 0.07% | 194 |
|
|
2024
Q4 | $403K | Buy |
4,051
+21
| +0.5% | +$2.17K | 0.1% | 150 |
|
|
2024
Q3 | $458K | Buy |
4,030
+903
| +29% | +$107K | 0.12% | 137 |
|
|
2024
Q2 | $387K | Buy |
3,127
+34
| +1% | +$4.38K | 0.15% | 141 |
|
|
2024
Q1 | $408K | Sell |
3,093
-78
| -2% | -$9.61K | 0.16% | 137 |
|
|
2023
Q4 | $346K | Buy |
3,171
+402
| +15% | +$41.7K | 0.16% | 136 |
|
|
2023
Q3 | $285K | Sell |
2,769
-2,036
| -42% | -$219K | 0.15% | 131 |
|
|
2023
Q2 | $554K | Buy |
4,805
+2,898
| +152% | +$329K | 0.28% | 70 |
|
|
2023
Q1 | $203K | Sell |
1,907
-157
| -8% | -$17K | 0.11% | 159 |
|
|
2022
Q4 | $229K | Buy |
2,064
+209
| +11% | +$21.4K | 0.13% | 123 |
|
|
2022
Q3 | $160K | Sell |
1,855
-396
| -18% | -$35.4K | 0.1% | 167 |
|
|
2022
Q2 | $205K | Buy |
+2,251
| New | +$200K | 0.12% | 153 |
|
|
2022
Q1 | – | Sell |
-2,209
| Closed | -$169K | – | 398 |
|
|
2021
Q4 | $169K | Buy |
2,209
+244
| +12% | +$19.4K | 0.08% | 174 |
|
|
2021
Q3 | $148K | Buy |
1,965
+5
| +0.3% | +$380 | 0.08% | 174 |
|
|
2021
Q2 | $152K | Sell |
1,960
-2,154
| -52% | -$160K | 0.08% | 170 |
|
|
2021
Q1 | $302K | Buy |
4,114
+1,320
| +47% | +$97.4K | 0.17% | 136 |
|
|
2020
Q4 | $217K | Buy |
2,794
+288
| +11% | +$22K | 0.15% | 144 |
|
|
2020
Q3 | $198K | Sell |
2,506
-1,039
| -29% | -$81.4K | 0.18% | 134 |
|
|
2020
Q2 | $260K | Buy |
3,545
+242
| +7% | +$18.2K | 0.27% | 77 |
|
|
2020
Q1 | $242K | Sell |
3,303
-252
| -7% | -$19.8K | 0.31% | 78 |
|
|
2019
Q4 | $309K | Buy |
3,555
+6
| +0.2% | +$493 | 0.21% | 106 |
|
|
2019
Q3 | $285K | Buy |
3,549
+7
| +0.2% | +$561 | 0.19% | 108 |
|
|
2019
Q2 | $283K | Sell |
3,542
-42
| -1% | -$3.22K | 0.19% | 111 |
|
|
2019
Q1 | $284K | Buy |
+3,584
| New | +$268K | 0.22% | 96 |
|
|
2018
Q3 | $298K | Buy |
+4,401
| New | +$280K | 0.14% | 138 |
|
Other funds holding MRK
Truvestments Capital's MRK Position: Q2 2026 in Review
Truvestments Capital increased its Merck (MRK) stake by 3.3% in Q2 2026, buying an estimated $94.9K and bringing the position to 25,027 shares worth $3.22M. The position accounts for 0.48% of the portfolio, ranked #52.
Truvestments Capital first reported a position in MRK in Q3 2018 and has held it in 30 quarters since. 3,820 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Truvestments Capital held 25,027 shares of Merck worth $3.22M as of Q2 2026.
- Truvestments Capital bought 811 Merck shares in Q2 2026, an estimated $94.9K.
- Merck made up 0.48% of Truvestments Capital's portfolio in Q2 2026, its #52 holding.
- Truvestments Capital first reported a position in Merck in Q3 2018 and has held it in 30 quarters since.
- 3,820 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.